Navigation Links
Spectrum Announces Fetal Bovine Serum Product Line
Date:7/24/2009

Spectrum now offers Fetal Bovine Serum (FBS) originating from abattoirs located in the US, Mexico, Canada, and Australia. In addition to untreated premium FBS, secondary treatments such as heat inactivation, dialysis, or gamma irradiation are available as standard catalog items. Spectrum also announced the availability of specialty pre-screened FBS for embryonic stem cell research. Each FBS order includes a full biochemical and chemical profile, as well as certification of the country of origin.

Gardena, CA (PRWEB) July 24, 2009 -- Spectrum Chemicals & Laboratory Products (Spectrum) announced the launch of a new line of premium quality Fetal Bovine Serum (FBS) ideal for many cell culture applications.

In partnership with an established biotechnology supplier, Spectrum now offers fetal bovine serum originating from abattoirs located in the US, Mexico, Canada, and Australia. Each FBS order includes a full biochemical and chemical profile, as well as certification of the country of origin. All of Spectrum's new serum products are in compliance with cGMP pharmaceutical standards, United States Department of Agriculture (USDA) guidelines, and the Food and Drug Administration (FDA) regulations.

In addition to untreated premium FBS, secondary treatments such as heat inactivation, dialysis, or gamma irradiation are available as standard catalog items. Spectrum also announced the availability of specialty pre-screened FBS for embryonic stem cell research. This serum is pre-tested for its ability to support the growth of undifferentiated colonies of embryonic stem cells so that additional testing at customer sites is minimized. Spectrum includes value-added services in support of their new FBS products, including a generous lot-reserve and sampling program.

"Spectrum is already a source for many of the reagents, lab supplies, and equipment used in cell culture applications, so it makes sense for us to offer a broad selection of growth media to enhance our position as a one-stop source for life science products", says Dr. Arnie Aistars, Chemicals Product Manager at Spectrum. He adds, "We are committed to increasing our profile in the life sciences and biotechnology markets and now have a great foundation on which to build".

About Spectrum Chemicals & Laboratory Products

Founded in 1971, Spectrum Chemicals & Laboratory Products manufacturers and distributes fine chemicals for production and laboratory facilities around the globe. All of Spectrum's worldwide facilities are ISO 9001 certified, and the California and New Jersey plants are FDA registered drug establishments and operate under current Good Manufacturing Practices (cGMP). For more information on Spectrum Chemicas & Laboratory Products, visit - http://www.SpectrumChemical.com.

###

Read the full story at http://www.prweb.com/releases/fetal-bovine-serum/stem-cell/prweb2670684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
3. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
4. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
5. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
6. Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
7. "Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science.
8. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spectrum Announces Fetal Bovine Serum Product Line
(Date:7/18/2017)... ... July 18, 2017 , ... Recently recognized by ... ) announces the migration of its flagship cloud-based product Planet Life Cycle – ... enterprise work management system that merges strategic and financial planning with execution. The ...
(Date:7/17/2017)... ... 17, 2017 , ... OHAUS Corporation, a leading worldwide manufacturer ... new line of Heavy-Duty Orbital Shakers today. , Eight New Models Available, OHAUS ... applications. These shakers are ideal for load capacities from 35 to 150 ...
(Date:7/17/2017)... ... 2017 , ... DuPont Pioneer today announced the launch of ... dedicated to connecting third-party innovators with DuPont Pioneer scientists is now available and ... and digital solutions. , “DuPont Pioneer is building on its long history of ...
(Date:7/14/2017)... ... , ... Sonic Manufacturing Technologies is proud to be an ... system on its roof top. “We will be independent of the grid and ... The company’s proud history of social responsibility and participation in the preservation of ...
Breaking Biology Technology:
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):